Barry Greene Net Worth & Insider Trades

Barry Greene - Director, Karyopharm Therapeutics Inc

As of August 15, 2022

What is Barry Greene's Net Worth?

The current estimated net worth of Karyopharm Therapeutics Inc's Director, Barry Greene, is estimated to be about $80.12M . Barry Greene owns about 3,000 units of Karyopharm Therapeutics Inc common stock. In the last 7 years at Karyopharm Therapeutics Inc, Barry Greene has sold an estimated value of $0 worth.

What is Barry Greene's Past Insider Trading?

Barry Greene's largest purchase order was 3,000 units , worth over $87.94K on April 6, 2015. In total, Barry Greene has made about 11 transactions over 7 years of their time at Karyopharm Therapeutics Inc. Barry Greene usually trades in May and June, with the busiest year in 2015, 2022 and 2020.

Ticker
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1

What is Barry Greene's' Mailing Address?

  • Mailing address is C/o Acorda Therapeutics 420 Saw Mill River Road Ardsley NY 10502 NY

What are Karyopharm Therapeutics Inc's Past Insider Trades?

Karyopharm Therapeutics Inc's most recent insider trade came on December 6, 2022 by Richard Paulson who sold 3,490 units worth $18.04K . In the last 9 years, insiders at Karyopharm Therapeutics Inc have sold an estimated value of $147.83M and bought an estimated value of $33.44M worth of shares. Insider trading is most common in February, with the busiest year in 2018. The most active traders at the company are Sharon Shacham, Chief Scientific Officer,  Michael Kauffman, Director,  and Andreas Hadjimichael .

Karyopharm Therapeutics Inc. Insider Trades

Date Range: All Time
Insider Names
Type
Value
Price per Share
Shares
Filing Date
No matching records found
1